Anti-HRSV F Recombinant Antibody (MEDI-493) (CAT#: MRO-1209LC)

This product is a recombinant humanized anti-Respiratory syncytial virus monoclonal antibody. MEDI-493 specifically binds to F glycoprotein associated with RSV and can be potentially used in the diagnosis and treatment of Respiratory syncytial virus infection.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Datasheet
  • MSDS
  • COA
Neut

Figure 1 Plaque-reduction assay of neutralization of RSV by MEDI-493.

Figure 1 Plaque-reduction assay of neutralization of RSV by MEDI-493.

O ^ RSV Long (A subtype) -f- MEDI-493; A = RSV 18537 (B subtype) H- MEDI-493; = RSV Long -I- RSV intravenous immune globulin (lot 4).

Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus

Neut

Figure 2 Microneutralization assay of MEDI-493 and RSV in- travenous immune globulin (IVIG) using clinical isolates of RSV.

Figure 2 Microneutralization assay of MEDI-493 and RSV in- travenous immune globulin (IVIG) using clinical isolates of RSV.

O = MEDI-493; = RSV IVIG; A ^ no antibody added.

Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus

PK

Figure 3 Single-dose serum pharmacokinetics and lung bio-distribution of palivizumab, AFFF and A4b4 in cotton rats.

Figure 3 Single-dose serum pharmacokinetics and lung bio-distribution of palivizumab, AFFF and A4b4 in cotton rats.

Antibodies at 3 mg/kg were administered by i.m. injection. Animals were bled retro-orbitally at various times after antibody infusion, and serum human IgG titers were measured by ELISA.

Development of Motavizumab, an Ultra-potent Antibody for the Prevention of Respiratory Syncytial Virus Infection in the Upper and Lower Respiratory Tract

PK

Figure 4 Pharmacokinetics of palivizumab, A4b4, A4b4-F52S (shown as F52S) and 493L1FR-S29R (motavizumab) in cynomolgus monkeys.

Figure 4 Pharmacokinetics of palivizumab, A4b4, A4b4-F52S (shown as F52S) and 493L1FR-S29R (motavizumab) in cynomolgus monkeys.

A single dose at 30 mg/kg of palivizumab or its variants was administered to cynomolgus monkeys by i.v. injection.

Development of Motavizumab, an Ultra-potent Antibody for the Prevention of Respiratory Syncytial Virus Infection in the Upper and Lower Respiratory Tract


Specifications

  • Host Species
  • Human
  • Derivation
  • Humanized
  • Type
  • Humanized antibody
  • Specificity
  • Human Respiratory syncytial virus
  • Clone
  • MEDI-493
  • Applications
  • ELISA, Neut, PK
  • Related Disease
  • Respiratory syncytial virus infection

Applications

  • Application Notes
  • The RSV F antibody has been reported in applications of Enzyme-linked Immunosorbent Assay, Neutralization, Pharmacokinetic.

Target

  • Alternative Names
  • Respiratory syncytial virus; RSV; Respiratory syncytial virus fusion glycoprotein; RSV F

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone MEDI-493"

See other products for "RSV F"

Humanized Antibody

CAT Product Name Application Type
TAB-009 Anti-RSV Recombinant Antibody (Palivizumab) IF, IP, Neut, FuncS, ELISA, FC, WB IgG1 - kappa
TAB-709 Anti-RSV glycoprotein F Recombinant Antibody (Motavizumab) IF, IP, Neut, FuncS, ELISA, FC, WB IgG1 - kappa
MRO-1209LC-S(P) Anti-HRSV F Recombinant Antibody scFv Fragment (MEDI-493) ELISA Humanized antibody
MRO-1209LC-F(E) Anti-HRSV F Recombinant Antibody Fab Fragment (MEDI-493) ELISA Humanized antibody

Recombinant Antibody

CAT Product Name Application Type
MRO-878LC Human Anti-RSV F Recombinant Antibody (MRO-878LC) ELISA, Neut Human IgG
HPAB-0293CQ Human Anti-RSV F Recombinant Antibody (HPAB-0293CQ) ELISA, Neut, FuncS Human IgG1
PABC-494 Recombinant Human Anti-RSV F Antibody (14N4) SPR, ELISA, Neut Human IgG1, κ
HPAB-0105-WJ Human Anti-RSV F Recombinant Antibody (HPAB-0105-WJ) ELISA, WB, Neut, IF, FC, Inhib, PK, IHC, DB Human IgG
PABJ-0100 Mouse Anti-RSV F Recombinant Antibody (clone R4.C6) ELISA, Neut Mouse IgG

ADCC Enhanced Antibody

CAT Product Name Application Type
AFC-TAB-009 Afuco™ Anti-RSV F ADCC Recombinant Antibody (Palivizumab), ADCC Enhanced IF, IP, Neut, FuncS, ELISA, FC ADCC enhanced antibody
AFC-TAB-709 Afuco™ Anti-RSV F ADCC Recombinant Antibody (Motavizumab), ADCC Enhanced IF, IP, Neut, FuncS, ELISA, FC ADCC enhanced antibody

MHC Tetramer for Virology

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for MRO-1209LC. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare